138 related articles for article (PubMed ID: 33653499)
1. Targeting Breast Cancer Using Hyaluronic Acid-Conjugated Liposomes Triggered with Ultrasound.
Ben Daya SM; Paul V; Awad NS; Al Sawaftah NM; Al Sayah MH; Husseini GA
J Biomed Nanotechnol; 2021 Jan; 17(1):90-99. PubMed ID: 33653499
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
Salkho NM; Paul V; Kawak P; Vitor RF; Martins AM; Al Sayah M; Husseini GA
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):462-472. PubMed ID: 29644867
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.
Awad NS; Paul V; Al-Sayah MH; Husseini GA
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):705-714. PubMed ID: 30873869
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.
Han NK; Shin DH; Kim JS; Weon KY; Jang CY; Kim JS
Int J Nanomedicine; 2016; 11():1413-25. PubMed ID: 27103799
[TBL] [Abstract][Full Text] [Related]
5. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
[TBL] [Abstract][Full Text] [Related]
6. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
7. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
[No Abstract] [Full Text] [Related]
8. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system.
AlSawaftah NM; Paul V; Kosaji D; Khabbaz L; Awad NS; Husseini GA
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):111-120. PubMed ID: 35543613
[TBL] [Abstract][Full Text] [Related]
11. Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes.
Awad NS; Paul V; Mahmoud MS; Al Sawaftah NM; Kawak PS; Al Sayah MH; Husseini GA
ACS Biomater Sci Eng; 2020 Jan; 6(1):48-57. PubMed ID: 33463192
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-triggered herceptin liposomes for breast cancer therapy.
Elamir A; Ajith S; Sawaftah NA; Abuwatfa W; Mukhopadhyay D; Paul V; Al-Sayah MH; Awad N; Husseini GA
Sci Rep; 2021 Apr; 11(1):7545. PubMed ID: 33824356
[TBL] [Abstract][Full Text] [Related]
13. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
[TBL] [Abstract][Full Text] [Related]
14. Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.
Alshaer W; Hillaireau H; Vergnaud J; Ismail S; Fattal E
Bioconjug Chem; 2015 Jul; 26(7):1307-13. PubMed ID: 25343502
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.
Qhattal HS; Hye T; Alali A; Liu X
ACS Nano; 2014 Jun; 8(6):5423-40. PubMed ID: 24806526
[TBL] [Abstract][Full Text] [Related]
16. Tunable conjugation densities of camptothecin on hyaluronic acid for tumor targeting and reduction-triggered release.
Chen Z; He N; Chen M; Zhao L; Li X
Acta Biomater; 2016 Oct; 43():195-207. PubMed ID: 27424081
[TBL] [Abstract][Full Text] [Related]
17. Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells.
AlSawaftah NM; Awad NS; Paul V; Kawak PS; Al-Sayah MH; Husseini GA
Sci Rep; 2021 Jun; 11(1):11589. PubMed ID: 34078930
[TBL] [Abstract][Full Text] [Related]
18. Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts.
Sine J; Urban C; Thayer D; Charron H; Valim N; Tata DB; Schiff R; Blumenthal R; Joshi A; Puri A
Int J Nanomedicine; 2015; 10():125-45. PubMed ID: 25565809
[TBL] [Abstract][Full Text] [Related]
19. Effect of phospholipid head group on ultrasound-triggered drug release and cellular uptake of immunoliposomes.
Awad NS; Paul V; AlSawaftah NM; Husseini GA
Sci Rep; 2023 Oct; 13(1):16644. PubMed ID: 37789072
[TBL] [Abstract][Full Text] [Related]
20. Selective Targeting and Restrictive Damage for Nonspecific Cells by Pulsed Laser-Activated Hyaluronan-Gold Nanoparticles.
Rau LR; Tsao SW; Liaw JW; Tsai SW
Biomacromolecules; 2016 Aug; 17(8):2514-21. PubMed ID: 27439142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
